Kyntra Bio (KYNB) Research & Development (2016 - 2025)
Historic Research & Development for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $1.2 million.
- Kyntra Bio's Research & Development fell 9394.71% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year decrease of 8137.8%. This contributed to the annual value of $95.7 million for FY2024, which is 6408.94% down from last year.
- According to the latest figures from Q3 2025, Kyntra Bio's Research & Development is $1.2 million, which was down 9394.71% from $5.9 million recorded in Q2 2025.
- In the past 5 years, Kyntra Bio's Research & Development registered a high of $122.6 million during Q2 2021, and its lowest value of $1.2 million during Q3 2025.
- In the last 5 years, Kyntra Bio's Research & Development had a median value of $61.6 million in 2022 and averaged $55.9 million.
- Per our database at Business Quant, Kyntra Bio's Research & Development skyrocketed by 9957.5% in 2021 and then tumbled by 9394.71% in 2025.
- Kyntra Bio's Research & Development (Quarter) stood at $113.9 million in 2021, then crashed by 45.9% to $61.6 million in 2022, then plummeted by 42.7% to $35.3 million in 2023, then plummeted by 80.55% to $6.9 million in 2024, then crashed by 82.4% to $1.2 million in 2025.
- Its Research & Development was $1.2 million in Q3 2025, compared to $5.9 million in Q2 2025 and $9.2 million in Q1 2025.